logo
Plus   Neg
Share
Email

Allergan: FDA Approves BOTOX For Pediatric Patients With Upper Limb Spasticity

Allergan plc (AGN) announced U.S. FDA approval of the company's sBLA for BOTOX for the treatment of pediatric patients with upper limb spasticity. BOTOX is the First Neurotoxin treatment approved to treat patients of, 2 to 17 years of age, for the therapeutic Indication. The approval was based on data from two Phase 3 studies evaluating BOTOX in over 200 pediatric patients.

The company's additional sBLA for the use of BOTOX to treat pediatric patients with lower limb spasticity, is currently under FDA review, and a decision is expected in the fourth quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network. Mitsubishi Motors North America inc. recalled 141,200 cars and sports utility vehicles (SUVs) due to potential corrosion of the front cross member because of salt water exposure such as from road salt use in cold-weather, according to the National Highway Traffic Safety Administration. The recall is expected to begin on July 14, 2020. The U.S. State of Arizona filed a consumer fraud lawsuit against Google alleging deceptive and unfair practices used to obtain users' location data. In the filing, Arizona Attorney General Mark Brnovich accused that the tech giant exploits these data for its lucrative advertising business. In a tweet, Brnovich said, "We brought forward this action to put a stop to Google's deceptive collection ...
RELATED NEWS
Follow RTT